ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Drops Objections To Bill For Research On Environmental Causes of Breast Cancer.

May 23, 2008

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

Murphy Withdraws From SU Position

October 17, 1986

Patient Advocacy: Survivorship Programs Win Funds To form Model Programs

December 13, 1996

Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years.

October 31, 2008

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001